Hemraj Singh Sikarwar

@wise.global.research.services.1747

Indore

10+ Years of experience

SEBI Registration INH000016719

Trade Ideas

161

Opinions

116

Followers

Expertise

Quantitative

Growth

Technical

Index Strategies

Market Commentary

Futures & Options

Technical Analysis

Trade Facts

Total Trades

Missed Trades

Profit Trades

Accuracy

Ask me Anything

Got a question? Ask me and I will answer it. Stay curious, stay hungry!

Posts

shared an insight ⚡️ 25th Oct

MANKIND PHARMA: SALES GROWTH AND PRODUCT MIX

MANKIND

is worth watching as investors prepare to assess its September-quarter performance. Pharmaceutical companies can benefit from a strong domestic formulation business, new product launches and improved distribution. However, growth should be evaluated alongside pricing, competition and marketing costs. What to monitor: - Domestic formulation revenue - Growth across key therapy segments - New product launches - Operating margins and expenses - Management guidance on future growth My view: A diversified product portfolio can support business resilience, but valuation and the sustainability of earnings growth remain critical. Investors should check whether the latest results support the expectations already reflected in the share price. Researchers Disclaimer: This analysis is for educational purposes only and represents the author's independent assessment. The author does not hold a position in the company discussed as of the date of this post. Please verify the latest company disclosures and consider your own risk tolerance before investing.

727

shared an insight ⚡️ 25th Oct

BANK OF MAHARASHTRA: PROFITABILITY AND ASSET QUALITY I

MAHABANK

is on the watchlist ahead of its September-quarter results. For public-sector banks, the quality of earnings depends on more than loan growth. Deposit mobilisation, net interest margins, recoveries and credit costs all influence sustainable profitability. Key factors to monitor: - Growth in advances and deposits - Net interest margin - Gross and net non-performing assets - Provisioning and recovery performance - Management outlook on credit growth My view: The upcoming results should help investors assess whether the bank can sustain growth while maintaining asset quality. A strong headline profit number is more meaningful when supported by healthy margins and controlled credit costs. Watch the official results and Monday’s market reaction before drawing a trading conclusion. Researchers Disclaimer: This analysis is for educational purposes only and represents the author's independent assessment. The author does not hold a position in the company discussed as of the date of this post. Please verify the latest company disclosures and consider your own risk tolerance before investing.

880

shared an insight ⚡️ 24th Oct

DALMIA BHARAT: CEMENT DEMAND AND EBITDA PER TONNE

DALBHARAT

is approaching its Q2 FY27 results, with investors likely to focus on sales volumes, realisations and cost efficiency. Cement companies operate in a competitive market where higher volumes do not always lead to higher profits. Fuel prices, freight costs, regional pricing and capacity utilisation can all affect margins. The company has scheduled an investor and analyst conference call for October 26 following its September-quarter results. What to track: - Cement sales volume growth - Realisation per tonne - EBITDA per tonne - Fuel, power and logistics costs - Capacity expansion and demand outlook My view: The quality of earnings will depend on whether volume growth is accompanied by stable or improving profitability. The results and management commentary should help investors evaluate the next phase of performance. This analysis is for educational purposes only and represents the author's independent assessment. The author does not hold a position in the company discussed as of the date of this post. Please verify the latest company disclosures and consider your own risk tolerance before investing.

834

What are the top stock recommendations by Hemraj Singh Sikarwar?

Hemraj Singh Sikarwar regularly shares stock views and market analysis on StockGro. Some of the stocks they have recently shared views on include MANKIND, MAHABANK and DALBHARAT. Explore Hemraj Singh Sikarwar's complete list of posts and trade views on their StockGro profile.

How can I follow Hemraj Singh Sikarwar's latest investment insights?

You can follow Hemraj Singh Sikarwar's latest investment insights, stock recommendations, and market analysis on StockGro App. Additionally, you can check their detailed stock analysis reports in the StockGro blog section.

What is Hemraj Singh Sikarwar's investment strategy?

Hemraj Singh Sikarwar follows a data-driven, research-backed investment strategy focused on maximizing returns while managing risk. Their approach includes fundamental and technical analysis, portfolio diversification, and sectoral trends to identify high-potential stocks.

How long has Hemraj Singh Sikarwar been a SEBI-registered Research Analyst (RA)?

Hemraj Singh Sikarwar has been a SEBI-registered Research Analyst and have 10+ Years of experience. With extensive experience in stock market analysis and investment research, they have guided investors in making informed and profitable decisions.

Where can I see Hemraj Singh Sikarwar's past performance and stock picks?

You can check Hemraj Singh Sikarwar's past stock recommendations, success rate, and investment insights on their StockGro profile. Their historical stock picks reflect a track record of strategic investment decisions based on thorough research.

How can I contact Hemraj Singh Sikarwar for stock market advice?

For stock market guidance from Hemraj Singh Sikarwar, you can connect through their StockGro profile. Some RAs may also provide personalized investment consultations based on their availability and SEBI regulations.

What is Hemraj Singh Sikarwar's track record in predicting market movements?

Hemraj Singh Sikarwar has a proven track record of accurate market analysis and trend predictions. By analyzing economic indicators, market sentiment, and technical charts, they have consistently helped investors make well-timed investment decisions.

What is the SEBI Registration number for Hemraj Singh Sikarwar?

Hemraj Singh Sikarwar is a SEBI-registered Research Analyst with the SEBI Registration INH000016719. This ensures that their investment recommendations comply with SEBI's regulatory framework for investor protection and financial advisory standards.

Be Financially Free with StockGro